NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

thanks senti, that’s the PR that I was looking for, but I thought it was after 2013 when those patents were issued and manufacturing protocols were transferred to London and Germany. Okay then I doubt those manufacturing changes were implemented for the trial.

I’ll take your educated word about the TFF work for DCVax-L, but I’m not sure that they would find it necessary to confirm that the work has been completed though. I think it’s highly likely that these manufacturing improvements have been implemented outside of the trial in the London facility manufacturing for the “specials” program, and I think Dr Ashkan could provide the Real World Evidence to support a regulatory approval. There’s a phrase that Northwest Bio said in regulatory filings years ago that has stuck with me:

“We believe the most important value of early access programs lies in the regulatory validation involved, and the invaluable opportunity to practice for commercialization outside of clinical trials and before actual commercialization.The opportunity for some early revenues is also encouraging, but in our view is secondary.”